done under the supervision of a healthcare professional to avoid worsening the underlying condition.
Tardive Dyskinesia-specific medications
The FDA has approved certain medications specifically for the treatment of TD, such as deutetrabenazine and valbenazine. These drugs work by reducing the amount of dopamine in the brain, which can help control involuntary movements.
Botulinum toxin injections
Injections of botulinum toxin (Botox) may be used to target specific muscle groups affected by TD, reducing the severity of involuntary movements.
Deep brain stimulation (DBS)
In severe cases of TD that do not respond to other treatments, DBS—a surgical procedure that involves implanting electrodes in the brain to modulate abnormal brain activity—may be considered.
Behavioral therapy
Counseling and behavioral therapies may help patients cope with the psychological and social challenges associated with TD.
Tardive dyskinesia is a complex neurological disorder that requires careful management. By understanding its symptoms, causes, and treatment options, healthcare providers can better support patients living with TD. Additionally, ongoing research into the underlying mechanisms of TD may lead to new and improved treatments in the future, offering hope for those affected by this condition.